GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Additional Paid-In Capital

PolyPeptide Group AG (XSWX:PPGN) Additional Paid-In Capital : CHF191.6 Mil(As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Additional Paid-In Capital?


PolyPeptide Group AG's quarterly additional paid-in capital declined from Dec. 2022 (CHF200.5 Mil) to Jun. 2023 (CHF198.2 Mil) but then stayed the same from Jun. 2023 (CHF198.2 Mil) to Dec. 2023 (CHF191.6 Mil).

PolyPeptide Group AG's annual additional paid-in capital declined from Dec. 2021 (CHF221.5 Mil) to Dec. 2022 (CHF200.5 Mil) and declined from Dec. 2022 (CHF200.5 Mil) to Dec. 2023 (CHF191.6 Mil).

PolyPeptide Group AG Additional Paid-In Capital Historical Data

The historical data trend for PolyPeptide Group AG's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Additional Paid-In Capital Chart

PolyPeptide Group AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 2.56 2.53 221.46 200.46 191.57

PolyPeptide Group AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only 221.46 208.33 200.46 198.16 191.57

PolyPeptide Group AG Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

PolyPeptide Group AG Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

PolyPeptide Group AG (XSWX:PPGN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Additional Paid-In Capital
Comparable Companies
BSP:SNCI11 BSP:OPCT3 BSP:ARML3 BSP:VAMO3 BSP:MILS3 BSP:VLID3 BSP:RENT3 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NBIX NSE:DIVISLAB BOM:500124
Traded in Other Exchanges
PPGNz:UK
Address
Neuhofstrasse 24, Baar, Zug, CHE, 6340
Website
https://www.polypeptide.com
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines